Literature DB >> 15016786

An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.

H Abdalla1, M Y Thum.   

Abstract

BACKGROUND: Many cycling women with elevated basal FSH level have been discouraged from undergoing IVF treatment. This is because elevated basal FSH is associated with poorer assisted reproduction treatment outcome. It has been argued that high FSH reflects not only reduced ovarian reserve but also poor oocyte quality. The aim of this study is to assess the value of treating cycling women who have elevated basal FSH and to assess the reasons for the reduction in both pregnancy rate (PR) and live birth rate (LBR).
METHODS: Between January 1997 and December 2001, 2057 patients underwent 3401 consecutive IVF/ICSI cycles in which the basal level of FSH (days 2-4) was determined at an earlier cycle. Analysis, however, was only performed for a single cycle per patient. All cases were divided into four cohorts according to FSH levels: group A, FSH <10 IU/ml; group B, 10.1-15 IU/ml; group C, 15.1-20 IU/ml; and group D, FSH >20 IU/ml. Each group was stratified further into subgroups according to age, < or =38 and >38 years.
RESULTS: Both PR (A, 32.3%; B, 19.8%; C, 17.5%; and D, 3%) and LBR (A, 24.7%; B, 13.2%; C, 13.8%; and D, 3%) were significantly reduced in the higher FSH level groups. LBR was significantly higher in the younger subgroups (A, 32.2%; B, 21.8%; C, 20%; and D, 16.7%) as compared with the older subgroups (A, 12.1%; B, 8.3%; C, 10.5%; and D, 0%). Higher levels of FSH were significantly associated with more cycle cancellation, a larger amount of gonadotrophin required to achieve follicular maturity, and a lower number of eggs collected, embryos available and embryos transferred. In all cases, however, there was no significant correlation between FSH levels and fertilization rate or miscarriage rate. Younger cycling women with elevated FSH had significantly higher LBR compared with older women with normal FSH (21.2% versus 12.1%). Furthermore, the cumulative LBR after three cycles in these younger patients with elevated FSH levels was 49.3%.
CONCLUSION: Although there is a reduction in both PR and LBR associated with higher levels of basal FSH, it is clear that in cycling women, high basal FSH is not a contraindication to IVF treatment, and a respectable PR and LBR can be achieved especially in young women. The reduction in PR and LBR is due to reduced reserve rather than poor oocyte quality. Clinics refusing to treat cycling women with elevated basal FSH levels may be denying these women a reasonable, albeit low, chance of achieving a birth with their own genetic material. Clinicians should use basal FSH levels as a guide to advise patients about their chances of achieving a live birth, not to exclude patients with a predicted lower success rate from a treatment programme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016786     DOI: 10.1093/humrep/deh141

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  30 in total

1.  Elevated basal FSH levels, if it is under 15 IU/L, will not reflect poor ART outcomes.

Authors:  Rieko Kojima; Koji Nakagawa; Akira Nakashima; Takashi Horikawa; Shirei Ohgi; Hidekazu Saito
Journal:  J Assist Reprod Genet       Date:  2008-01-29       Impact factor: 3.412

2.  Persistent organic pollutants as predictors of increased FSH:LH ratio in naturally cycling, reproductive age women.

Authors:  Mia V Gallo; Julia Ravenscroft; David O Carpenter; Lawrence M Schell
Journal:  Environ Res       Date:  2018-04-02       Impact factor: 6.498

3.  Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization.

Authors:  Lubna Pal; Sangita Jindal; Barry R Witt; Nanette Santoro
Journal:  Fertil Steril       Date:  2008-04-28       Impact factor: 7.329

4.  Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women.

Authors:  Berna Seckin; Figen Turkcapar; Gulnur Ozaksit
Journal:  J Assist Reprod Genet       Date:  2011-12-20       Impact factor: 3.412

5.  Activin Decoy Receptor ActRIIB:Fc Lowers FSH and Therapeutically Restores Oocyte Yield, Prevents Oocyte Chromosome Misalignments and Spindle Aberrations, and Increases Fertility in Midlife Female SAMP8 Mice.

Authors:  Lori R Bernstein; Amelia C L Mackenzie; Se-Jin Lee; Charles L Chaffin; István Merchenthaler
Journal:  Endocrinology       Date:  2015-12-29       Impact factor: 4.736

6.  Elevated basal FSH and embryo quality: lessons from extended culture embryos: raised FSH and blastocyst quality.

Authors:  M Y Thum; E Kalu; H Abdalla
Journal:  J Assist Reprod Genet       Date:  2009-06-10       Impact factor: 3.412

7.  Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2010-06-17       Impact factor: 5.211

8.  Total fertilization failure: is it the end of the story?

Authors:  Inci Kahyaoglu; Berfu Demir; Ayten Turkkanı; Ozgur Cınar; Serdar Dilbaz; Berna Dilbaz; Leyla Mollamahmutoglu
Journal:  J Assist Reprod Genet       Date:  2014-06-25       Impact factor: 3.412

9.  Prediction of pregnancy in IVF cycles on the fourth day of ovarian stimulation.

Authors:  J Carrera-Rotllan; L Estrada-García; J Sarquella-Ventura
Journal:  J Assist Reprod Genet       Date:  2007-06-28       Impact factor: 3.412

Review 10.  Biological versus chronological ovarian age: implications for assisted reproductive technology.

Authors:  Carlo Alviggi; Peter Humaidan; Colin M Howles; Donald Tredway; Stephen G Hillier
Journal:  Reprod Biol Endocrinol       Date:  2009-09-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.